Attention to improving clinical work and scientific research of peritoneal dialysis in China

doi:10.3877/cma.j.issn.2095-3216.2015.01.001

Abstract

Abstract:

Peritoneal dialysis (PD) can be a simple and convenient, safe and effective home treatment, and has become an alternative treatment for end-stage renal disease. China is the most populous country, and the number of PD patients continued to rise in recent years with both the popularity of urban and rural basic medical insurance system and the national health policy control. PD in China is facing new opportunities and challenges, and it is imperative to pay attention to clinical technological improvements and scientific research and exploration of PD in China. The present editorial aimed to introduce the situation and challenge of PD in China, optimize the individualized PD treatment regimen for Chinese patients in order to improve the quality of treatment by evidence-based medicine, strengthen the management of quality control, strive to build PD treatment homogeneity, consolidate PD research foundation, and expand the product area of PD-related independent intellectual property, so as to provide new thoughts for clinical and basic research on PD to get greater social and economic benefits.

Key words: Peritoneal dialysis, End-stage renal disease, Continuous ambulatory peritoneal dialysis

Xiangmei Chen, Xueying Cao. Attention to improving clinical work and scientific research of peritoneal dialysis in China[J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2015, 04(01): 1-4.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhsbyjdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-3216.2015.01.001

https://zhsbyjdzzz.cma-cmc.com.cn/EN/Y2015/V04/I01/1

References 18

[1]	中华医学会肾脏病分会透析移植登记工作组. 1999年度全国透析移植登记报告[J]. 中华肾脏病杂志，2001, 17(2): 77-78.
[2]	Blake PG, Wilkie M. Peritoneal dialysis in China: a story of growth and innovation[J]. Perit Dial Int, 2014, 34(Suppl 2): S27-S28.
[3]	Jain AK, Blake P, Cordy P, et al. Global trends in rates of peritoneal dialysis[J]. J Am Soc Nephrol, 2012, 23(3): 533-544.
[4]	Burkart JM. The ADEMEX study and PD adequacy[J]. Blood Purif, 2003, 21(1): 37-41.
[5]	Churchill DN. Implications of the Canada-USA (CANUSA) study of the adequacy of dialysis on peritoneal dialysis schedule[J]. Nephrol Dial Transplant, 1998, 13(Suppl 6): 158-163.
[6]	Diaz-Buxo JA, White SA, Himmele R. The importance of residual renal function in peritoneal dialysis patients[J]. Adv Perit Dial, 2013, 29: 19-24.
[7]	Marron B, Remon C, Perez-Fontan M, et al. Benefits of preserving residual renal function in peritoneal dialysis[J]. Kidney Int Suppl, 2008, (108): S42-S51.
[8]	Moist LM, Port FK, Orzol SM, et al. Predictors of loss of residual renal function among new dialysis patients[J]. J Am Soc Nephrol, 2000, 11(3): 556-564.
[9]	Liao CT, Chen YM, Shiao CC, et al. Rate of decline of residual renal function is associated with all-cause mortality and technique failure in patients on long-term peritoneal dialysis[J]. Nephrol Dial Transplant, 2009, 24(9): 2909-2914.
[10]	李伟．腹膜透析患者的营养管理[J]．中华肾病研究电子杂志，2015, 4(1): 14-18.
[11]	倪兆慧，金海姣．自动化腹膜透析的应用[J]．中华肾病研究电子杂志，2015, 4(1)：10-13.
[12]	陈香美. 腹膜透析标准操作规程[J]．人民军医出版社，2010.
[13]	林洪丽，李龙凯．腹膜透析患者的容量管理[J]．中华肾病研究电子杂志，2015, 4(1): 5-9.
[14]	Johnson DW, Brown FG, Clarke M, et al. The effect of low glucose degradation product, neutral pH versus standard peritoneal dialysis solutions on peritoneal membrane function: the balANZ trial[J]．Nephrol Dial Transplant, 2012, 27(12): 4445-4453.
[15]	Johnson DW, Brown FG, Clarke M, et al. Effects of biocompatible versus standard fluid on peritoneal dialysis outcomes[J]. J Am Soc Nephrol, 2012, 23(6): 1097-1107.
[16]	Oliver MJ, Verrelli M, Zacharias JM, et al. Choosing peritoneal dialysis reduces the risk of invasive access interventions[J]. Nephrol Dial Transplant, 2012, 27(2): 810-816.
[17]	Davies SJ. Peritoneal dialysis－current status and future challenges[J]. Nat Rev Nephrol, 2013, 9(7): 399-408.
[18]	夏天．常用腹膜透析导管类型及导管相关性并发症[J]．中华肾病研究电子杂志，2015, 4(1): 19-21.

Please choose a citation manager

Content to export